Kegler Brown Hill & Ritter Co., L.P.A. v. Croce

2025 Ohio 1627
CourtOhio Court of Appeals
DecidedMay 6, 2025
Docket23AP-9
StatusPublished

This text of 2025 Ohio 1627 (Kegler Brown Hill & Ritter Co., L.P.A. v. Croce) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kegler Brown Hill & Ritter Co., L.P.A. v. Croce, 2025 Ohio 1627 (Ohio Ct. App. 2025).

Opinion

[Cite as Kegler Brown Hill & Ritter Co., L.P.A. v. Croce, 2025-Ohio-1627.]

IN THE COURT OF APPEALS OF OHIO

TENTH APPELLATE DISTRICT

Kegler Brown Hill & Ritter Co., L.P.A., :

Plaintiff-Appellee, : No. 23AP-9 v. : (C.P.C. No. 20CV-3954)

Carlo M. Croce, M.D., : (REGULAR CALENDAR)

Defendant-Appellant. :

D E C I S I O N

Rendered on May 6, 2025

On brief: Cooper Elliott, Charles H. Cooper, C. Benjamin Cooper, and Rex H. Elliott, for appellee. Argued: C. Benjamin Cooper.

On brief: Johrendt & Holford, and Andrew Mills Holford, for appellant. Argued: Andrew Mills Holford.

APPEAL from the Franklin County Court of Common Pleas

MENTEL, J.

{¶ 1} Defendant-appellant, Carlo M. Croce, M.D., appeals from the judgment entered in the Franklin County Court of Common Pleas after a jury awarded plaintiff- appellee, Kegler Brown Hill & Ritter Co., L.P.A. (“Kegler Brown”), slightly over one million dollars in damages in unpaid attorney fees and prejudgment interest. Dr. Croce asserted a defense in recoupment, which the trial court rejected after a bench trial. On appeal, Dr. Croce argues that the trial court violated his right to a jury trial by not allowing him to present his defense to the jury, failing to find the element of proximate cause in his defense after the bench trial, and excluding a portion of his expert witness’s testimony not expressed in the expert’s report. As explained below, we conclude that Dr. Croce had a right to have No. 23AP-9 2

a jury hear his defense. We therefore reverse the bench trial verdict, rendering the assertion of error arising from that verdict moot. Furthermore, we find no error in the trial court’s decision to exclude a portion of the expert’s testimony, and therefore affirm in part and reverse in part. I. Facts and Procedural History {¶ 2} Dr. Croce is a research scientist at the Ohio State University who studies the genetic causes of cancer. (Oct. 28, 2022 Tr. Vol IV at 879-80.) He has authored hundreds of scientific papers and is the recipient of “about 60” national and international awards recognizing his research. Id. at 888. {¶ 3} On November 23, 2016, a New York Times reporter, James Glanz, sent Dr. Croce a letter stating that he was preparing an article investigating “allegations” of “improper data manipulation and duplication . . . and plagiarism” that had resulted in the retraction and correction of “at least 15” scientific papers authored or co-authored by Dr. Croce. (Pl.’s Ex. 1 at 1.) The letter described “at least two whistleblowers,” including a molecular virologist at Purdue University, David A. Sanders, who had “lodged over a dozen complaints” about Dr. Croce’s work with the scientific journals that had published them. Id. Dr. Sanders’ complaints had resulted in “at least four” corrections, the letter said, but “in other cases, Dr. Croce and colleagues [had] successfully disputed the claims and prevented corrections or retractions from being issued.” Id. The letter contained 25 detailed questions about the accusations, as well as Dr. Croce’s professional history, interactions with university officials arising from misconduct allegations involving a colleague, and the alleged use of his work by tobacco companies and their expert witnesses in the 1990s to cast doubt on the causal link between smoking and cancer.1 Id. {¶ 4} After receiving the letter, Dr. Croce retained Kegler Brown, seeking “to avoid an article in The New York Times based on that garbage,” as well as “a retraction and an apology” from the reporter, James Glanz, and Dr. Sanders. (Oct. 28, 2022 Tr. Vol IV at 896.) On December 13, 2016, Dr. Croce signed an agreement authorizing the firm “to advise

1 When dismissing Dr. Croce’s claim against the New York Times, the federal district court noted that the

article “informs the reader of Dr. Croce’s long-held belief that smoking is a primary cause of lung cancer and of his statement that he was ‘unaware’ the industry was using his research,” and included as well “his disclaimer that any use of his research or name to the contrary was ‘false and fraudulent.’ ” Croce v. New York Times Co., 345 F.Supp.3d 961, 982 (S.D.Ohio 2018). No. 23AP-9 3

and represent [him] regarding claims arising from statements and accusations” by James Glanz and Dr. Sanders that Dr. Croce believed to be “false and defamatory.” (Joint Trial Ex. 1, hereinafter “Engagement Agreement”.) As stated in the Engagement Agreement, the scope of representation include[d] investigating the falsity of [the statements and accusations] and pursuing the appropriate course of action against the responsible parties who may be liable for their publication, which course of action will, if appropriate and authorized by [Dr. Croce], include filing and prosecuting a lawsuit . . . in the United States District Court for the Southern District of Ohio against the appropriate defendants, which may include The New York Times, James Glanz, David A. Sanders, and, if the facts and the law merit it, Purdue University. (Engagement Agreement at 1.) {¶ 5} The agreement specified the hourly rates of two attorneys and a paralegal assigned to the matter. In addition, Dr. Croce agreed to be billed monthly for attorney fees and expenses, and to remit payment to the firm within 30 days of billing. {¶ 6} For the next year and a half, Kegler Brown represented Dr. Croce on these matters, which led to the filing of two civil suits in federal court. The first lawsuit, filed against Dr. Sanders in the Franklin County Court of Common Pleas on March 2, 2017, alleged claims of defamation per se and intentional infliction of emotional distress. The New York Times published Mr. Glanz’s article a week later. The case against Dr. Sanders was removed to the United States District Court for the Southern District of Ohio on April 21, 2017, where he later prevailed on summary judgment against Dr. Croce. See Croce v. Sanders, 459 F.Supp.3d 997 (S.D.Ohio 2020) (granting summary judgment) and Croce v. Sanders, 843 Fed.Appx. 710 (6th Cir. 2021) (affirming grant of summary judgment). {¶ 7} Kegler Brown filed suit against the New York Times on Dr. Croce’s behalf in federal district court on May 10, 2017, alleging defamation, false light, and intentional infliction of emotional distress. On November 6, 2018, the district court granted a motion to dismiss for failure to state a claim upon which relief may be granted, but allowed a claim of defamation based on one statement that Dr. Croce eventually agreed to dismiss. See Croce v. New York Times Co., 345 F.Supp.3d 961 (S.D.Ohio 2018) (granting motion to dismiss) and Croce v. New York Times Co., 930 F.3d 787 (6th Cir. 2019) (affirming dismissal). No. 23AP-9 4

{¶ 8} Kegler Brown had ended its relationship with Dr. Croce well before the termination of the lawsuits it filed for him, however. By the summer of 2017, Dr. Croce was behind on his payments to the firm. (Tr. at 373.) He paid the firm over $522,000 on August 22, 2017, and said that he would be auctioning off several paintings to free up cash. Id. at 373-74. But, by the end of November, he owed the firm over $358,000, and the unpaid balance continued to grow. Id. at 374. On July 10, 2018, attorney Thomas Hill emailed Dr. Croce about an overdue balance of $887,451.55, asking for an explanation about a promised payment by wire transfer that had never materialized. (Pl.’s Ex. P-203.) Three days later, Mr. Hill emailed Dr. Croce and informed him that Kegler Brown had “no alternative” but to file motions to withdraw as his counsel in the pending defamation cases, and to withdraw as his legal counsel in matters related to the university’s investigation in the misconduct allegations. (Pl.’s Ex. P-204.) Dr. Croce responded, stating “you have done a remarkable job and I thank you.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Colgrove v. Battin
413 U.S. 149 (Supreme Court, 1973)
Langenkamp v. Culp
498 U.S. 42 (Supreme Court, 1991)
Container Recycling Alliance v. Lassman
359 B.R. 358 (D. Massachusetts, 2007)
Turturice v. Aep Energy Servs., Inc., 06ap-1214 (4-17-2008)
2008 Ohio 1835 (Ohio Court of Appeals, 2008)
Star Bank National Ass'n v. Cirrocumulus Ltd. Partnership
700 N.E.2d 918 (Ohio Court of Appeals, 1997)
Ireland v. Cheney
196 N.E. 267 (Ohio Supreme Court, 1935)
Cleveland Ry. Co. v. Halliday
188 N.E. 1 (Ohio Supreme Court, 1933)
Belding v. State Ex Rel. Heifner
169 N.E. 301 (Ohio Supreme Court, 1929)
Carlo Croce v. New York Times Co.
930 F.3d 787 (Sixth Circuit, 2019)
Sutherland v. Gaylor
2021 Ohio 1941 (Ohio Court of Appeals, 2021)
Riley v. Montgomery
463 N.E.2d 1246 (Ohio Supreme Court, 1984)
Nakoff v. Fairview General Hospital
662 N.E.2d 1 (Ohio Supreme Court, 1996)
Croce v. N.Y. Times Co.
345 F. Supp. 3d 961 (S.D. Ohio, 2018)
McClain v. State
2022 Ohio 4722 (Ohio Supreme Court, 2022)
Mohammadpour v. Haghighi
2023 Ohio 4211 (Ohio Court of Appeals, 2023)
State ex rel. Dillon v. Indus. Comm.
2024 Ohio 744 (Ohio Supreme Court, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
2025 Ohio 1627, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kegler-brown-hill-ritter-co-lpa-v-croce-ohioctapp-2025.